What Does Science Say About Pet Allergies?

If spending time around dogs or cats makes your eyes water, your nose run, your skin itch or your breathing difficult, you’re not alone.

Pet allergies — allergic reactions to proteins found in an animal's skin cells, saliva or urine — affect 10% to 20% of people worldwide, and exposure isn’t limited to pet owners. ...

New Texas Law Could Change How Food Additives Are Labeled Nationwide

Texas has become the first state to require warning labels on thousands of food and beverages containing common 44 dyes or additives.

The new law — signed Sunday by Republican Gov. Greg Abbott — is expected to set off a nationwide scramble in the food industry, The Washington Post reported. 

The industry mus...

Stem Cell Treatment May Free Some With Type 1 Diabetes From Insulin

A single infusion of a new stem cell-based treatment may have helped 10 out of 12 people with severe type 1 diabetes stop using insulin, researchers report.

The treatment, called zimislecel, was made by Vertex Pharmaceuticals. It’s an infusion of lab-grown islet cells — special cells that help regulate blood sugar, according to...

Nearly 30 People in England Get Rare Illness After Botox

Dozens of people in northeastern England have developed a rare and dangerous illness after receiving Botox injections, according to health officials in the U.K.

At least 28 people have reported symptoms of botulism, a potentially deadly illness that attacks the nervous system, after undergoing cosmetic procedures, the U.K. Health Security ...

Child Dies After Suspected E. Coli Outbreak Linked To Butcher Shops in France

A 12-year-old girl has died and seven other children were sickened after a suspected outbreak of a rare foodborne illness in northern France.

Before getting sick, French officials say, all of the children had eaten meat products from two butcher shops (boucheries) in the city of Saint-Quentin, about 80 miles northeast of Paris. The first c...

VR Might Aid Stroke Recovery

Virtual reality (VR) training might help stroke survivors regain their arm movement, a new evidence review says.

The results indicate that VR could be a promising tool to boost rehab efforts, mainly by increasing the amount of therapy patients receive, researchers said.

"Spending more time in therapy is known to improve outcomes afte...

Weighted Vests Don't Protect Bone Health In Dieting Seniors, Trial Says

Weighted vests have been touted as a potential means of warding off osteoporosis while losing weight.

The idea is that the extra weight will promote new bone growth even as people are walking or jogging to lose weight.

But this idea isn’t backed up by results, a new clinical trial says.

Seniors with obesity who wore weigh...

Studies Address Muscle Loss Caused By GLP-1 Drugs

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with fat.

Experts are now turning their attention toward helping GLP-1 patients maintain muscle while dropping fat, according to a pair of new studies presented at the American Diabetes Association’s annual meeting...

Blood Test Might Predict MS Relapse

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says.

Blood levels of a protein called neurofilament light chain rise significantly in MS patients up to a year before they have a relapse, researchers reported Monday at a meeting of the European Academy of Neurology in...

Cystic Fibrosis: Symptoms, Treatments, Causes & More

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. 

An autosomal recessive disorder is a genetic condition in which an affected person has inherited a mutated gene from each parent.

In CF, mutations in the CF trans...

Rival GLP-1 Weight-Loss Drug Emerges From China

A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to blockbuster drugs Ozempic/Wegovy and Zepbound, clinical trial results show.

Ecnoglutide helped people lose between 9% to 13% of their body weight on average after 40 weeks of treatment, according to phase 3 trial findings published June 21 in The Lancet Diab...